Controlled-substance prescriptions

Controlled-Substance Prescriptions

Controlled substances carry the highest risk for misuse, diversion, and patient harm, so federal and state law impose strict rules on how these prescriptions are written, dispensed, transferred, and tracked. As a pharmacy technician, your role is to check every incoming controlled-substance prescription for completeness and flag any problem to the pharmacist before processing begins.

DEA Schedules and Why They Matter

The Drug Enforcement Administration (DEA) places controlled substances into Schedules I through V based on accepted medical use and potential for dependence. Schedules II through V are dispensed in pharmacies. Schedule II drugs (e.g., oxycodone, amphetamine salts, fentanyl) carry the strictest dispensing rules; Schedule V drugs (e.g., some cough preparations with small amounts of codeine) carry the least restrictive rules, though they are still controlled.

Required Elements on a Controlled-Substance Prescription

Federal law requires every controlled-substance prescription to include:

• Patient's full name and address
• Date issued (the date the prescriber signed or authorized it)
• Drug name, strength, and quantity to be dispensed
• Directions for use (sig)
• Prescriber's name, address, and DEA registration number
• Prescriber's manual signature (for written prescriptions)

States may add requirements, such as the patient's date of birth, a tamper-resistant paper format, or a specific quantity written out in words. Always know your state's additional requirements. If any required element is missing or illegible, do not process the prescription — bring it to the pharmacist immediately.

Refill Rules by Schedule

• Schedule II: No refills are permitted under federal law. Each dispensing event requires a new, valid prescription.
• Schedules III and IV: Up to five refills within six months of the issue date.
• Schedule V: Up to five refills within six months, unless state law is more restrictive.

After the refill limit or the six-month window expires, whichever comes first, the prescription is no longer valid and the patient must obtain a new one.

Partial Fills

A pharmacist may partially fill a Schedule II prescription when the full quantity is not in stock or when the patient or prescriber requests a smaller amount. The remaining quantity must be dispensed within 30 days of the original issue date; after that, the balance is void and a new prescription is required. Terminally ill patients and long-term care facility residents have longer windows under federal regulations — confirm these details with the pharmacist for such patients.

For Schedules III–V, partial fills are treated like refills and count toward the refill limit.

Transfers

Schedule III, IV, and V prescriptions may be transferred between pharmacies once (one time only). If two pharmacies share a real-time electronic database, federal rules allow multiple transfers up to the maximum refill limit. Schedule II prescriptions may not be transferred — each fill requires a new original prescription sent directly to the dispensing pharmacy.

When a transfer occurs, the sending pharmacy must record specific information (date, transferring pharmacist, receiving pharmacy details) and mark the original as transferred. The receiving pharmacy records the original prescription data. Technicians assist with gathering this information but transfers must be handled pharmacist-to-pharmacist.

Electronic Prescribing for Controlled Substances (EPCS)

The DEA permits electronic prescribing for controlled substances (EPCS) when both the prescriber and pharmacy meet DEA security standards. An EPCS must be digitally signed by the prescriber using an identity-verified credential. When you receive an EPCS, verify that the software-generated prescription contains all required elements. EPCS records are maintained electronically; the pharmacy must be able to print or display them for inspection. Some states require EPCS for certain controlled substances — know your state's mandate.

Prescription Monitoring Programs (PMPs / PDMPs)

Every state operates a Prescription Drug Monitoring Program (PDMP), a secure, state-run database that records dispensing of controlled substances. Before dispensing, the pharmacist (and in some states the technician under pharmacist supervision) checks the PDMP to identify patterns such as:

• Multiple prescriptions from different prescribers ("doctor shopping")
• Dangerously overlapping opioid and benzodiazepine prescriptions
• Quantities inconsistent with legitimate medical use

Many states require a PDMP check before dispensing Schedule II or III medications. Technicians often perform the data-entry steps of the look-up and present the report to the pharmacist, who makes the clinical decision. Never discuss a patient's PDMP record with anyone other than the supervising pharmacist — this information is protected.

Safety Points

• Verify the DEA number. A simple check: the two letters of a prescriber's DEA number are followed by seven digits; the last digit can be verified using the DEA checksum algorithm. Report any mismatch to the pharmacist.
• Do not accept altered prescriptions. Signs include different ink colors, erasures, or quantities that appear changed. Fraudulent prescriptions are a criminal matter — the pharmacist decides how to proceed.
• Scope of practice: Technicians identify missing elements and flag concerns; only the pharmacist may contact prescribers, make clinical judgments, or refuse a prescription.
• Documentation: Controlled-substance records must be kept for a minimum of two years under federal law (states may require longer), and Schedule II records must be kept separately or readily retrievable.